Hyperinsulinemic-euglycemic clamp studies also showed systemic insulin resistance, enhanced gluconeogenesis, accompanied by impaired insulin signaling and elevated gluconeogenic gene expression in the liver (Fig. 3g–i), although the impairment was not evident in skeletal muscle (Fig. 3g and Supplementary Fig. 6d). The gene discussed is INS; the disease is Insulin resistance.